Cleveland Magazine’s Post

The second episode of Unlocking the Fatty Liver Mistry is here! ✨ 💡 Rebranding Fatty Liver Disease: What’s in a Name? From NAFLD to MASLD and NASH to MASH—Dr. Mistry breaks down the recent nomenclature changes in fatty liver disease and explains why these updates are so important. Learn about: ➡️ What these new terms mean ➡️ The reasoning behind the change ➡️ Why it matters for patients and healthcare providers Watch right here: https://bit.ly/3Cb4SOO #FattyLiverDisease #MedicalEducation #LiverHealth

Protect Your Liver Health! Inflammation, fibrosis, and cirrhosis are steps in the silent progression of liver disease. Early intervention can halt this process and keep your liver strong. Say goodbye to uncertainty and consult us today for peace of mind.  Visit us: https://lnkd.in/d3PiCi3p . . #liverdisease #liverhealth #livertreatment #livercare #liverawareness #earlydetection #liverfibrosis #livercirrhosis #liverfailure #hepatology #liverfunction #livercheckup #fibrosisawareness #cirrhosisawareness #liverwellness #chronicliverdisease #liverproblems #liverconditions #liverdiagnosis #livercarematters #livercheckup #drvineetgautam #indore

Liver fibrosis is a gradual process that can go unnoticed until it becomes severe. Here’s what happens: Gradual scarring of liver tissue due to long-term damage. Caused by chronic liver diseases like hepatitis or fatty liver. Scarring disrupts normal liver function over time. Early detection can help manage and slow progression. Advanced fibrosis may lead to cirrhosis or liver failure. Remember, taking care of your liver today can prevent severe complications tomorrow. #liverhealth #liverfibrosis #livercare #liverdoctor #healthawareness #wellness #preventivecare #healthtips #loveyourliver #medicaleducation

January is Love Your Liver Month. It is a vital opportunity to highlight the importance of liver health and address the leading causes of liver disease. This annual observance shines a spotlight on research efforts aimed at preventing, treating, and potentially curing liver diseases. One such initiative making waves is the Alcochange trial here at Leeds Teaching Hospitals NHS Trust, which aims to deliver a groundbreaking digital intervention for patients battling Alcohol-Related Liver Disease. Read about this trial ➡️ https://lnkd.in/eCXweDfA #Loveyourlivermonth #liver #research

October is Liver Awareness Month, yet, many of us are unaware of the serious impact of liver disease, especially hyperammonemia—a condition that can cause brain edema, coma, and other severe complications. With over 5 million people in the U.S. living with cirrhosis, current treatments just aren’t enough, especially in emergency situations. That’s why we developed AAPC-300, designed to remove over 80% of ammonia from the bloodstream in less than 1.5 hours. This is a huge step in preventing life-altering damage for those battling liver disease. Join me in helping raise awareness of this critical condition. #LiverAwarenessMonth #LiverDisease #MedicalDevices #Innovation

The liver is the hardworking hero of your body, responsible for over 500 different functions, yet it’s often overlooked. Did you know that when your liver stops working properly, almost everything else in your body does too? While that may sound alarming, the good news is there’s so much we can do to keep our livers healthy. With Dry January and Love Your Liver Month in full swing, awareness about this vital organ is growing. In our latest article on our website, we’ve spoken to consultant gastroenterologist and hepatologist Andy King. From the liver’s essential role in everyday health to what’s behind the rise in liver disease in the UK, and most importantly, how you can protect your liver, he covers it all. https://lnkd.in/eD_6qdE4

Sickle cell disease (SCD) is a group of inherited blood disorders characterized by the presence of abnormally shaped red blood cells. These cells, shaped like a crescent or "sickle," cause a range of health complications due to their inability to flow smoothly through blood vessels, leading to blockages, reduced oxygen delivery, and organ damage. https://lnkd.in/gjWvGKUV #BhaloTheko

Heart disease remains the leading cause of death in the United States, with coronary heart disease accounting for 41.2% of cardiovascular-related deaths in 2020. The "Heart-in-a-Box" technology, also known as the TransMedics Organ Care System (OCS), preserves donor hearts in a warm, functioning state during transport. This system circulates blood, nutrients, and medications through the heart, keeping it beating and viable for up to 12 hours—twice as long as traditional cold storage methods. By extending preservation time and allowing for the assessment of heart function during transport, "Heart-in-a-Box" increases the availability of suitable donor hearts. This advancement offers new hope to heart disease patients awaiting transplants, potentially reducing wait times and improving outcomes. #ClinicalTrials #ClinicalInnovation #DrugDevelopment #MedicalAdvancements #ClinicalInsights #HealthcareInnovation #PatientCareResearch #ClinicalExcellence #FutureOfMedicine #ClinicalResearch #MedicalResearch #PharmaIndustry #DrugDevelopment #ClinicalDevelopment #ResearchAndDevelopment #LifeSciences #OncologyResearch

Thanks for sharing this great article Kate. A few things jump out: 1) There is still a lot of misunderstanding around liver disease, and it's promising to see conditions like metabolic liver disease attracting more attention in the general media. This article explains the issues perfectly! A huge percentage of people with liver disease do not drink alcohol. 2) There is a danger that when we talk about 1 in 3 people having liver disease, policymakers become paralyzed by the scale of the issue. It's important to note that whilst, according to some reports, 30% of us have some degree of excess fat in our livers, not all will progress to cirrhosis, cancer or liver failure. 3) This is an urgent issue that needs addressing now. Liver-related mortality rates are trending in the wrong direction, unlike most other diseases. More people are developing steatotic (fatty) liver disease, and as comorbidities (like type 2 diabetes) become more common, people are getting sicker, quicker. Add to this the advent of new treatments including Madrigal Pharmaceuticals Resmetirom. We think that one of the keys to getting ahead of this Tsunami* (*credit Roger Green) lies in intelligence gathering and deployment. If you can use real-world data to recognize the patterns in those cases that do progress from simple steatosis to advanced disease, we're no longer talking about treating 1 in 3. We can then use a case-finding approach, and historic blood tests to find these high-risk people BEFORE they progress. “The life depends on the liver”. We couldn't have said it better ourselves. #liverdisease #publichealth #FattyLiver p.s. Thanks to New Scientist for yet another great article.

High phosphorus (hyperphosphatemia) is a common complication caused by chronic kidney disease. Tune in to learn more about why this happens and how to successfully manage high phosphorus in CKD. https://bit.ly/459UfV1